All News | FDA

Advertising & Promotion

Aug 29, 2022
Court Allows Federal FCA Case Against Abbott to Proceed
Aug 24, 2022
Optical Lens Maker To Pay $22 Million To Resolve False Claims Liability Tied to Alleged Kickbacks
Aug 22, 2022
Study Finds DTC Heart Drug Ads Have Little Effect on Lifestyle Intentions
Aug 14, 2022
Risk Info in CSL Communications Aids Consumer Recognition, Study Finds
Aug 1, 2022
FTC Opens Endorsement and Testimonial Guide Revisions for Public Comment
Jul 29, 2022
Device Maker Settles Kickback Allegations
Jul 25, 2022
FDA Issues Warning Letter Over Compounded Drug Claims
Jul 15, 2022
House Bill Would Set Deadline for FDA’s Final Rule on DTC Prescription Drug Ads
Jul 8, 2022
FTC Consent Order Bans Two Companies and Owner from Advertising or Selling Dietary Supplements
Jul 1, 2022
Release of FDA’s Final Rule on DTC Drug Ads Pushed to May 2023

Good Clinical Practice

Oct 28, 2022
FDA Goes Beyond ICH Advice on Dealing with Multiple Endpoints in Clinical Trials
Oct 22, 2022
SACHRP Counsels FDA on Common Rule Harmonization
Oct 14, 2022
Owners of Another Miami Clinical Site Charged with Data Fabrication
Oct 11, 2022
FDA Details Ethical Considerations for Pediatric Trials
Oct 2, 2022
FDA Proposes Regulations To Harmonize with Revised Common Rule
Sep 23, 2022
OHRP Issues Two Determination Letters
Sep 18, 2022
New Draft Guidance on Clinical Pharmacology Considerations for Pediatric Studies Expands 2014 Guidance
Sep 12, 2022
Work Group Issues Recommendations To Improve Communication with Subjects When Trials End Early
Sep 6, 2022
ORI Opens 'Brainstorming Process' for Research Misconduct Rule Revision
Aug 26, 2022
FDA Provides Additional Answers on Charging for Investigational Drugs

U.S. Food Labeling

Nov 21,2021
FSIS Extends Comment Period on Labeling Cell Cultured Meat, Poultry
Nov 18,2021
Biden Nominates Dr. Robert Califf To Head the FDA Again as Commissioner of Food and Drugs
Nov 10,2021
FDA Revises Temporary Marketing Permit Guidance To Streamline Process
Oct 28,2021
Supplement Firm Enjoined From Selling Violative Products
Oct 14,2021
FDA Publishes Guidance Setting Voluntary Sodium Reduction Targets for Food
Sep 30,2021
FSIS Revises Guideline on Food Products Packaged as Kits
Sep 15,2021
FSIS Asks for Comments on Cell Cultured Meat, Poultry Labeling
Sep 1,2021
Congress Again Moves To Mandate Updates to Food Labeling
Aug 19,2021
FDA Rejects NDIs for CBD Products Intended To Be Marketed as Dietary Supplements
Aug 4,2021
Courts in Three Separate Product Actions Side With Trader Joe’s

FDA Regulation & Enforcement

Medical Devices

Copyright © Thompson FDA, a division of CBIS. All rights reserved.